SMA Newborn Screening Kits
This is a contract result notice, not an open opportunity. Details from the official award data.
The Scottish Newborn Screening Laboratory has been commissioned to participate in the in-service evaluation for Spinal Muscular Atrophy (SMA) organised by the National Screening Committee.
NHSGG&C require newborn screening kits that measure both SMN1 and SMN2 genes simultaneously.
The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol.
The requirement is to screen dried blood spot samples from newborn babies for Spinal Muscular Atrophy (SMA).
What the supplier must deliver
The SMN2 copy number must be screened
The SMN2 copy number must be screened for at the same time as the SMN1 deletion in keeping with the Scottish screening protocol.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at NHS Greater Glasgow and Clyde, and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- ocds-h6vhtk-066e98
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 031045-2026
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
NHS Greater Glasgow and Clyde’s tender network
Assembling the network…